Read + Share
Amedeo Smart
Independent Medical Education
Slomski A. No Benefit for Lopinavir-Ritonavir in Severe COVID-19. JAMA 2020;323:1999.PMID: 32453363
Email
LinkedIn
Facebook
Twitter
Privacy Policy